Nutex Health Inc. reported financial results for the second quarter and first half of 2026 ending June 30, 2026. Net income attributable to Nutex Health surged to $112.6 million ($15.87 diluted EPS) for the six-month period, compared to $3.5 million in the prior year. Total revenue decreased 6.3% to $427.2 million due to lower arbitration-related costs following a favorable retroactive amendment with HaloMD and reduced CMS administrative fees, which lowered contract services expenses by $52.3 million. Adjusted EBITDA for the six months reached $147.5 million. The company holds $205.2 million in cash and $31.1 million in long-term debt. Nutex Health operates a healthcare management and operations business comprising 27 hospital facilities across 12 states and a primary care physician network.
